Evolent Health logo
Evolent Health EVH
$ 32.44 0.0%

Quarterly report 2023-Q3
added 11-02-2023

report update icon

Evolent Health Financial Ratios 2011-2024 | EVH

Annual Financial Ratios Evolent Health

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-171.2 -61.0 -5.1 -2.9 -25.2 -15.1 -5.1 0.7 - - - -

P/S

8.6 9.2 1.9 1.0 2.1 2.1 3.2 2.6 - - - -

EPS

-0.2 -0.4 -3.9 -3.7 -0.7 -0.9 -3.5 13.1 -13.5 2.5 - -

EV (Enterprise Value)

4.05 B 2.75 B 2.1 B 1.33 B 1.63 B 942 M 973 M 183 M 40.3 M 70.9 M - -

EBITDA per Share

0.76 0.2 -2.37 -0.722 -0.0914 -0.623 -1.37 -1.42 - - - -

EV/EBITDA

153.0 126.4 -17.8 -187.0 -19.9 -13.1 -2.9 - - - -

PEG

-0.85 -0.46 -0.03 0.01 -0.91 -0.2 0.04 0.0 - - - -

P/B

3.8 3.3 2.8 0.9 1.1 0.9 0.9 0.3 - - - -

P/CF

-283.9 59.2 -105.5 -11.1 -22.1 -16.4 -16.1 -9.9 - - - -

ROE %

-2.23 -5.42 -53.95 -32.50 -4.43 -5.80 -17.51 35.58 - - - -

ROA %

-1.05 -2.65 -24.39 -20.16 -3.06 -4.62 -13.31 32.74 - - - -

ROCE %

0.42 -6.11 -42.42 -9.23 -3.55 -6.14 -7.39 -4.49 - - - -

Current Ratio

1.9 2.0 1.8 1.2 1.8 2.8 2.0 3.1 - - - -

DSO

210.3 253.7 48.4 33.4 47.9 57.9 58.3 76.8 - - - -

DIO

- - - - - - - - - - - -

DPO

27.0 35.6 18.2 26.7 163.4 58.2 103.2 106.2 - - - -

Operating Cycle

210.3 253.7 48.4 33.4 47.9 57.9 58.3 76.8 - - - -

Cash Conversion Cycle

183.2 218.1 30.2 6.7 -115.5 -0.3 -44.9 -29.4 - - - -

All numbers in USD currency

Quarterly Financial Ratios Evolent Health

2023-Q3 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.3 - 0.02 - -0.06 0.03 -0.15 -0.11 -0.12 -0.17 -0.44 -2.38 -0.93 -2360 -0.3 -0.38 -0.59 -0.21 -0.16 -0.13 -0.18 -0.18 -0.18 -0.28 -0.34 -0.33 -0.26 -0.2 -2.91 -0.1 -0.29 25.69 -4.22 -4.37 -2.07 -3.17 -3.35 - - - - - - - - - - - -

EBITDA per Share

0.13 - 0.32 - 0.14 - 0.45 0.08 -0.01 - 0.35 -2.27 -0.11 - 0.3 0.05 -0.41 - 0.24 0.14 -0.06 - 0.1 -0.09 -0.28 - -0.12 -0.13 -4.07 - -0.32 -0.76 - - - - - - - - - - - - - - - - -

ROE %

-2.69 -1.50 -2.32 -3.84 -5.32 -6.03 -7.58 -11.46 -42.82 -50.53 -69.65 -66.39 -36.97 -32.74 -12.72 -11.04 -8.48 -4.60 -4.45 -4.61 -5.41 -6.00 -7.18 -7.53 -7.05 -22.74 -20.89 -21.14 35.48 51.20 568.65 1790.11 2954.30 2956.04 2439.23 1219.61 - - - - - - - - - - - - -

ROA %

-1.11 -0.68 -1.08 -1.84 -2.54 -2.89 -3.56 -5.24 -19.38 -24.05 -36.21 -35.19 -22.47 -20.16 -7.90 -6.92 -5.39 -3.06 -3.09 -3.33 -4.04 -4.62 -5.07 -5.04 -4.46 -13.31 -12.27 -12.51 23.63 32.74 4.39 -60.39 -161.78 -160.67 -131.91 -65.96 - - - - - - - - - - - - -

ROCE %

0.93 0.60 -0.49 -2.62 -3.87 -4.92 -7.57 -9.14 -44.34 -42.06 -44.25 -43.78 -10.06 -9.98 -10.94 -9.72 -7.77 -2.98 -4.37 -4.79 -5.90 -5.40 -7.66 -8.52 -8.43 -28.97 -31.63 -32.03 -32.01 -4.43 -4.43 -1.78 - - - - - - - - - - - - - - - - -

Current Ratio

1.9 - 1.9 - 1.8 2.0 1.9 1.9 1.9 1.8 1.8 1.8 2.4 2.6 2.6 2.6 2.6 3.2 3.2 3.2 3.2 4.9 4.9 4.9 4.9 4.2 4.2 4.2 4.2 12.6 12.6 12.6 12.6 - 35.6 35.6 - - - - - - - - - - - - -

DSO

37.9 - 26.1 - 56.3 67.3 94.2 97.6 81.6 57.6 46.1 46.7 39.1 27.8 29.4 31.7 25.6 29.6 44.9 42.1 36.9 39.3 41.4 41.7 38.5 - -8276.7 -264853.1 - - - -110.4 -82.2 - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

6.1 - 10.6 - - - 21.7 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

37.9 - 26.1 - 56.3 67.3 94.2 97.6 81.6 57.6 46.1 46.7 39.1 27.8 29.4 31.7 25.6 29.6 44.9 42.1 36.9 39.3 41.4 41.7 38.5 - -8276.7 -264853.1 - - - -110.4 -82.2 - - - - - - - - - - - - - - - -

Cash Conversion Cycle

31.8 - 15.5 - 56.3 67.3 72.4 97.6 81.6 57.6 46.1 46.7 39.1 27.8 29.4 31.7 25.6 29.6 44.9 42.1 36.9 39.3 41.4 41.7 38.5 - -8276.7 -264853.1 - - - -110.4 -82.2 - - - - - - - - - - - - - - - -

All numbers in USD currency